Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater

Conventional active sludge (AS) process at municipal centralized wastewater treatment facilities may exhibit little pharmaceuticals (PhACs) removal efficiencies when treating hospital wastewater (HWW). Therefore, a dedicated efficient wastewater treatment at the source point is recommended. In this sense, advanced oxidation processes (AOPs) and fungal treatment (FG) have evidenced promising results in degrading PhACs. The coupling of the AOP based on UV/H2O2 treatment with biological treatment (AS or FG) treating a real non-sterile HWW, was evaluated in this work. In addition, a coagulation-flocculation pretreatment was applied to improve the efficiency of all approaches. Twenty-two PhACs were detected in raw HWW, which were effectively removed (93–95%) with the combination of any of the biological treatment followed by UV/H2O2 treatment. Similar removal results (94%) were obtained when placing UV/H2O2 treatment before FG, while a lower removal (83%) was obtained in the combination of UV/H2O2 followed by AS. However, the latest was the only treatment combination that achieved a decrease in the toxicity of water. Moreover, deconjugation of conjugated PhACs has been suggested for ofloxacin and lorazepam after AS treatment, and for ketoprofen after fungal treatment. Monitoring of carbamazepine and its transformation products along the treatment allowed to identify the same carbamazepine degradation pathway in UV/H2O2 and AS treatments, unlike fungal treatment, which followed another degradation route.

Saved in:
Bibliographic Details
Main Authors: Mir-Tutusaus, Josep Anton, Jaén-Gil, Adrián, Barceló, Damià, Buttiglieri, Gianluigi, González-Olmos, Rafael, Rodríguez-Mozaz, Sara, Caminal, Glòria, Sarrà, Montserrat
Other Authors: Ministerio de Economía y Competitividad (España)
Format: artículo biblioteca
Language:English
Published: Elsevier 2021-06-15
Subjects:AOPs, Fungal treatment, Hospital wastewater, Activated sludge, UV/H2O2, Decentralized treatment,
Online Access:http://hdl.handle.net/10261/234093
http://dx.doi.org/10.13039/501100003329
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-idaea-es-10261-234093
record_format koha
spelling dig-idaea-es-10261-2340932021-03-12T04:54:57Z Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater Mir-Tutusaus, Josep Anton Jaén-Gil, Adrián Barceló, Damià Buttiglieri, Gianluigi González-Olmos, Rafael Rodríguez-Mozaz, Sara Caminal, Glòria Sarrà, Montserrat Ministerio de Economía y Competitividad (España) Barceló, Damià [0000-0002-8873-0491] Caminal, Glòria [0000-0001-9646-6099] AOPs Fungal treatment Hospital wastewater Activated sludge UV/H2O2 Decentralized treatment Conventional active sludge (AS) process at municipal centralized wastewater treatment facilities may exhibit little pharmaceuticals (PhACs) removal efficiencies when treating hospital wastewater (HWW). Therefore, a dedicated efficient wastewater treatment at the source point is recommended. In this sense, advanced oxidation processes (AOPs) and fungal treatment (FG) have evidenced promising results in degrading PhACs. The coupling of the AOP based on UV/H2O2 treatment with biological treatment (AS or FG) treating a real non-sterile HWW, was evaluated in this work. In addition, a coagulation-flocculation pretreatment was applied to improve the efficiency of all approaches. Twenty-two PhACs were detected in raw HWW, which were effectively removed (93–95%) with the combination of any of the biological treatment followed by UV/H2O2 treatment. Similar removal results (94%) were obtained when placing UV/H2O2 treatment before FG, while a lower removal (83%) was obtained in the combination of UV/H2O2 followed by AS. However, the latest was the only treatment combination that achieved a decrease in the toxicity of water. Moreover, deconjugation of conjugated PhACs has been suggested for ofloxacin and lorazepam after AS treatment, and for ketoprofen after fungal treatment. Monitoring of carbamazepine and its transformation products along the treatment allowed to identify the same carbamazepine degradation pathway in UV/H2O2 and AS treatments, unlike fungal treatment, which followed another degradation route. This work has been funded by the Spanish Ministry of Economy and Competitiveness (project CTM 2013-48545-C2-1-R) and partly supported by the Generalitat de Catalunya (Consolidated Research Groups 2017-SGR-0014, 2017 SGR 1124 and 2017-SGR1404). J. A. Mir-Tutusaus acknowledges the predoctoral grant from UAB. S. Rodriguez-Mozaz and R. Gonzalez-Olmos acknowledge the “Redes de Excelencia 2015” program (CTM2015-71054-REDT). S. Rodriguez-Mozaz and G. Buttiglieri acknowledge the Ramon y Cajal research fellowships (RYC-2014- 16707 and RYC-2014-16754) as well as CLEaN-TOUR (CTM2017-85385-C2-1-R), from the Spanish Ministry of Economy and Competitiveness. Adrián Jaén-Gil acknowledges the predoctoral grant 2019FI_B2_00202 from AGAUR and co-financed by the European Social Fund. ICRA researchers thank funding from CERCA program. We would like to thank Sant Joan de Déu Hospital staff for their collaboration during the sampling campaign and Aleix Benito for his support in the laboratory with the UV/H2O2 experiments. Peer reviewed 2021-03-11T07:24:39Z 2021-03-11T07:24:39Z 2021-06-15 artículo http://purl.org/coar/resource_type/c_6501 Science of the Total Environment 773:145374 (2021) http://hdl.handle.net/10261/234093 10.1016/j.scitotenv.2021.145374 http://dx.doi.org/10.13039/501100003329 en #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/CTM 2013-48545-C2-1-R Postprint https://doi.org/10.1016/j.scitotenv.2021.145374 Sí embargo_20230615 Elsevier
institution IDAEA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-idaea-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del IDAEA España
language English
topic AOPs
Fungal treatment
Hospital wastewater
Activated sludge
UV/H2O2
Decentralized treatment
AOPs
Fungal treatment
Hospital wastewater
Activated sludge
UV/H2O2
Decentralized treatment
spellingShingle AOPs
Fungal treatment
Hospital wastewater
Activated sludge
UV/H2O2
Decentralized treatment
AOPs
Fungal treatment
Hospital wastewater
Activated sludge
UV/H2O2
Decentralized treatment
Mir-Tutusaus, Josep Anton
Jaén-Gil, Adrián
Barceló, Damià
Buttiglieri, Gianluigi
González-Olmos, Rafael
Rodríguez-Mozaz, Sara
Caminal, Glòria
Sarrà, Montserrat
Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater
description Conventional active sludge (AS) process at municipal centralized wastewater treatment facilities may exhibit little pharmaceuticals (PhACs) removal efficiencies when treating hospital wastewater (HWW). Therefore, a dedicated efficient wastewater treatment at the source point is recommended. In this sense, advanced oxidation processes (AOPs) and fungal treatment (FG) have evidenced promising results in degrading PhACs. The coupling of the AOP based on UV/H2O2 treatment with biological treatment (AS or FG) treating a real non-sterile HWW, was evaluated in this work. In addition, a coagulation-flocculation pretreatment was applied to improve the efficiency of all approaches. Twenty-two PhACs were detected in raw HWW, which were effectively removed (93–95%) with the combination of any of the biological treatment followed by UV/H2O2 treatment. Similar removal results (94%) were obtained when placing UV/H2O2 treatment before FG, while a lower removal (83%) was obtained in the combination of UV/H2O2 followed by AS. However, the latest was the only treatment combination that achieved a decrease in the toxicity of water. Moreover, deconjugation of conjugated PhACs has been suggested for ofloxacin and lorazepam after AS treatment, and for ketoprofen after fungal treatment. Monitoring of carbamazepine and its transformation products along the treatment allowed to identify the same carbamazepine degradation pathway in UV/H2O2 and AS treatments, unlike fungal treatment, which followed another degradation route.
author2 Ministerio de Economía y Competitividad (España)
author_facet Ministerio de Economía y Competitividad (España)
Mir-Tutusaus, Josep Anton
Jaén-Gil, Adrián
Barceló, Damià
Buttiglieri, Gianluigi
González-Olmos, Rafael
Rodríguez-Mozaz, Sara
Caminal, Glòria
Sarrà, Montserrat
format artículo
topic_facet AOPs
Fungal treatment
Hospital wastewater
Activated sludge
UV/H2O2
Decentralized treatment
author Mir-Tutusaus, Josep Anton
Jaén-Gil, Adrián
Barceló, Damià
Buttiglieri, Gianluigi
González-Olmos, Rafael
Rodríguez-Mozaz, Sara
Caminal, Glòria
Sarrà, Montserrat
author_sort Mir-Tutusaus, Josep Anton
title Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater
title_short Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater
title_full Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater
title_fullStr Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater
title_full_unstemmed Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater
title_sort prospects on coupling uv/h2o2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater
publisher Elsevier
publishDate 2021-06-15
url http://hdl.handle.net/10261/234093
http://dx.doi.org/10.13039/501100003329
work_keys_str_mv AT mirtutusausjosepanton prospectsoncouplinguvh2o2withactivatedsludgeorafungaltreatmentfortheremovalofpharmaceuticallyactivecompoundsinrealhospitalwastewater
AT jaengiladrian prospectsoncouplinguvh2o2withactivatedsludgeorafungaltreatmentfortheremovalofpharmaceuticallyactivecompoundsinrealhospitalwastewater
AT barcelodamia prospectsoncouplinguvh2o2withactivatedsludgeorafungaltreatmentfortheremovalofpharmaceuticallyactivecompoundsinrealhospitalwastewater
AT buttiglierigianluigi prospectsoncouplinguvh2o2withactivatedsludgeorafungaltreatmentfortheremovalofpharmaceuticallyactivecompoundsinrealhospitalwastewater
AT gonzalezolmosrafael prospectsoncouplinguvh2o2withactivatedsludgeorafungaltreatmentfortheremovalofpharmaceuticallyactivecompoundsinrealhospitalwastewater
AT rodriguezmozazsara prospectsoncouplinguvh2o2withactivatedsludgeorafungaltreatmentfortheremovalofpharmaceuticallyactivecompoundsinrealhospitalwastewater
AT caminalgloria prospectsoncouplinguvh2o2withactivatedsludgeorafungaltreatmentfortheremovalofpharmaceuticallyactivecompoundsinrealhospitalwastewater
AT sarramontserrat prospectsoncouplinguvh2o2withactivatedsludgeorafungaltreatmentfortheremovalofpharmaceuticallyactivecompoundsinrealhospitalwastewater
_version_ 1777669508199088128